Reformulary_Logo.png
Reformulary Group’s prescription drug tool receives TELUS Outstanding Product Award
16 mai 2018 13h22 HE | Reformulary Group
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Last night at the 33rd annual Canadian Advanced Technology Alliance Leadership Awards Gala, Reformulary Group received the TELUS Outstanding Product...
Expert group to revi
Expert group to review evidence for use of medical cannabis for employer plans
16 mai 2018 12h53 HE | Reformulary Group
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Today, Reformulary Group, Canada’s leading, independent drug plan management company, announced its Cannabis Formulary Committee, which will review the best...